Yüklüyor......
Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis
INTRODUCTION: Sialidosis is a neurosomatic, lysosomal storage disease (LSD) caused by mutations in the NEU1 gene, encoding the lysosomal sialidase NEU1. Deficient enzyme activity results in impaired processing/degradation of sialo-glycoproteins, and accumulation of oversialylated metabolites. Sialid...
Kaydedildi:
| Yayımlandı: | Expert Opin Orphan Drugs |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4777310/ https://ncbi.nlm.nih.gov/pubmed/26949572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2015.1025746 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|